| Catalog Number |
8065752917 |
| Medical Device Problem Code |
Obstruction of Flow (2423)
|
| Health Effect - Clinical Codes |
Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
07/02/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).H.10 reflects all related report numbers associated with this product event that have been submitted at this time.
|
| |
|
Event or Problem Description
|
|
A nurse reported phacoemulsification tip was blocked during the sculpt mode of cataract surgery (with intraocular lens implant) and there was no aspiration of ophthalmic viscosurgical devices (ovds) and balanced salt solution (bss).The surgery was completed after replacing the product with another one.There was no report of patient impact.This report pertains to phacoemulsification tip involved in this reported event.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information provided in h.6.And h.11.No technical inquiries were received from the customer.A sample was not received at the manufacturing site for evaluation; therefore, the condition of the product could not be verified.A review of the device history record traceable to the reported lot number, indicates that the reported product was processed and released according to the reported product¿s acceptance criteria.The investigation conducted a non-conformance review of the reported lot number.No deviations were identified and all corresponding production release specifications defined in the device master record were met.Based on the evaluation of the information received, the investigation was unable to identify the root cause or origin of the reported event.Additionally, no manufacturing-related deficiencies were found that potentially could have contributed to the complaint.As the root cause and its origin are inconclusive, further investigative or manufacturing actions are not warranted at this time.All phacoemulsification (phaco) tips are 100% visually inspected by trained operators using 30x magnification during the manufacturing process.Receipt of additional relevant information or supporting materials will prompt a re-evaluation of the complaint investigation.Complaint data for all products is reviewed monthly to monitor for adverse trends.During the last review, no adverse trends were observed for the reported product and event combination.Quality assurance has reviewed this complaint and will continue to monitor data for evidence of adverse trending and take further action, as appropriate.No further action warranted at this time.The manufacturer internal reference number is: (b)(4).H.10 reflects all related report numbers associated with this product event that have been submitted at this time.
|
| |
|
Additional Manufacturer Narrative
|
|
Corrected information provided in b.5.And h.6 [food and drug administration (fda) patient event codes].Investigation results also updated (incomplete sample returned).Additional information provided in h.3., h.6.And h.11.No technical inquiries were received from the customer.One open tray with a cassette and tubing was received at the investigation site; however, no phaco tip was returned for evaluation for the report; therefore, the condition of the product could not be verified.A review of the device history record traceable to the reported lot number, indicates that the reported product was processed and released according to the reported product¿s acceptance criteria.The investigation conducted a non-conformance review of the reported lot number.No deviations were identified and all corresponding production release specifications defined in the device master record were met.Based on the evaluation of the information, since the sample was not received at the manufacturing site, how and when the tip was blocked was unable to identify the root cause or origin of the reported event.As the root cause and its origin are inconclusive, further investigative or manufacturing actions are not warranted at this time.All phaco tips are 100% visually inspected by trained operators using 30 times magnification during the manufacturing process.Receipt of additional relevant information or supporting materials will prompt a re-evaluation of the complaint investigation.Complaint data for all company products is reviewed monthly to monitor for adverse trends.During the last review, no adverse trends were observed for the reported product and event combination.Quality assurance has reviewed this complaint and will continue to monitor data for evidence of adverse trending and take further action, as appropriate.No further action warranted at this time.The manufacturer internal reference number is: (b)(4).
|
| |
|
Event or Problem Description
|
|
A nurse reported phacoemulsification tip was blocked during the sculpt mode of cataract surgery (with intraocular lens implant) and there was no aspiration of ophthalmic viscosurgical devices (ovds) and balanced salt solution (bss).The surgery was completed smoothly with the same handpiece and the new pak with the new phaco tip.There was no impact to the patient.This report pertains to phacoemulsification tip involved in this reported event.
|
| |
|
Search Alerts/Recalls
|